Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2026-01-01 @ 6:12 PM
Study NCT ID:
NCT00320359
Status:
COMPLETED
Last Update Posted:
2017-03-01
First Post:
2006-05-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-08
Start Date Type:
None
Primary Completion Date:
2007-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-01
First Submit QC Date:
None
Study First Post Date:
2006-05-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-27
Last Update Post Date:
2017-03-01
Last Update Post Date Type:
ACTUAL